https://ukinvestormagazine.co.uk/astrazeneca-post-positive-results-for-anaemia-medication/ UK Investor Magazine provides breaking financial news and investment ideas Tue, 21 Jan 2020 16:38:44 +0000 hourly 1 https://wordpress.org/?v=6.8.5 https://ukinvestormagazine.co.uk/astrazeneca-post-positive-results-for-anaemia-medication/#comment-13810 Tue, 21 Jan 2020 16:38:44 +0000 https://ukinvestormagazine.co.uk/?p=23772#comment-13810 […] this update, a collaboration deal with with US based FibroGen (NASDAQ: FGEN) for Roxadustat was announced which saw the firms shares in […]

]]> https://ukinvestormagazine.co.uk/astrazeneca-post-positive-results-for-anaemia-medication/#comment-13800 Tue, 21 Jan 2020 15:32:59 +0000 https://ukinvestormagazine.co.uk/?p=23772#comment-13800 […] November, the firm once again hit the bullseye. The FTSE100 listed firm won the approval for Roxadustat in China, and also won access to the Japanese market for the treatment of dialysis patients with anaemia […]

]]> https://ukinvestormagazine.co.uk/astrazeneca-post-positive-results-for-anaemia-medication/#comment-13454 Mon, 06 Jan 2020 10:37:00 +0000 https://ukinvestormagazine.co.uk/?p=23772#comment-13454 […] AstraZeneca said that the Lokelma drug has been approved in China for the treatment of hyperkalaemia and Farxiga granted a priority review by the US Food & Drug Administration. […]

]]>